12 Health Care Stocks Moving In Friday's After-Market Session

Gainers

• Coherus BioSciences CHRS shares moved upwards by 11.7% to $2.95 during Friday's after-market session. Today's trading volume for this security ended up closing at 1.4 million shares, which is 55.1 percent of its average volume over the last 100 days. The company's market cap stands at $313.8 million.
• Aligos Therapeutics ALGS stock increased by 11.56% to $0.69. The market value of their outstanding shares is at $30.0 million.
• ContraFect CFRX shares moved upwards by 11.36% to $0.3. The market value of their outstanding shares is at $1.6 million.
• ProKidney PROK shares rose 9.61% to $1.65. The market value of their outstanding shares is at $101.6 million.
• Virpax Pharmaceuticals VRPX stock moved upwards by 8.1% to $0.8. The company's market cap stands at $9.3 million.
• Reviva Pharmaceuticals RVPH shares increased by 7.99% to $4.05. The company's market cap stands at $91.7 million.

Losers

• Connect Biopharma Hldgs CNTB stock declined by 10.0% to $1.24 during Friday's after-market session. The market value of their outstanding shares is at $68.3 million.
• SeaStar Medical Holding ICU stock decreased by 8.0% to $0.94. At the close, SeaStar Medical Holding's trading volume reached 8.5 million shares. This is 64.8% of its average volume over the last 100 days. The company's market cap stands at $18.2 million.
• Allarity Therapeutics ALLR shares fell 6.93% to $0.56. The company's market cap stands at $2.3 million.
• Lipella Pharmaceuticals LIPO stock decreased by 6.41% to $1.17. The company's market cap stands at $6.7 million.
• Sight Sciences SGHT stock fell 5.34% to $1.42. This security traded at a volume of 152.4K shares come close, making up 49.1% of its average volume over the last 100 days. The company's market cap stands at $69.0 million.
• MSP Recovery LIFW stock fell 5.33% to $1.6. This security traded at a volume of 210.3K shares come close, making up 12.1% of its average volume over the last 100 days. The company's market cap stands at $21.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.